Showing results (2081-2090 of 8,030) with videos related to

Sort By:
Pageof 803
The Oncologist|November 18, 2011
Approval summary: letrozole (Femara® tablets) for adjuvant and extended adjuvant postmenopausal breast cancer treatment: conversion of accelerated to full approvalMartin H Cohen, John R Johnson, Robert Justice, et al.
Science (New York, N.Y.)|August 26, 2006
Decoupled plant and insect diversity after the end-Cretaceous extinctionPeter Wilf, Conrad C Labandeira, Kirk R Johnson, et al.
Nano Letters|December 12, 2007
Probing the structure of DNA-carbon nanotube hybrids with molecular dynamicsRobert R Johnson, A T Charlie Johnson, Michael L Klein
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 28, 2002
Increase in bile flow and biliary excretion of glutathione-derived sulfhydryls in rats by drug-metabolizing enzyme inducers is mediated by multidrug resistance protein 2David R Johnson, Sultan S M Habeebu, Curtis D Klaassen
Sexually Transmitted Diseases|December 19, 1998
Treponemal specific tests for the serodiagnosis of syphilis. Syphilis and HIV Study GroupM Augenbraun, R Rolfs, R Johnson, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 1, 1997
Physical activity related energy expenditure and fat mass in young childrenM I Goran, G Hunter, T R Nagy, et al.
Journal of Clinical Microbiology|May 18, 2012
Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infectionsNatasha E Holmes, Paul D R Johnson, Benjamin P Howden
The American Journal of Physiology|March 1, 1982
Mucosal gastrin receptor. VII. Up- and downregulationG R Speir, K Takeuchi, W Peitsch, et al.
Transfusion|March 16, 2002
Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor plateletsR Molnar, R Johnson, L T Sweat, et al.
Clinical Immunology and Immunopathology|April 1, 1984
Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosageR I Schiff, C Rudd, R Johnson, et al.
Pageof 803